financetom
Business
financetom
/
Business
/
Newsletter | This 21-year-old has built a Rs 500 Cr company that aims to shatter the drug retail industry; Apple WWDC 2023 & more
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Newsletter | This 21-year-old has built a Rs 500 Cr company that aims to shatter the drug retail industry; Apple WWDC 2023 & more
Jun 5, 2023 3:17 AM

Here's a rundown of 11 significant news stories to keep you in the know:

Share Market Live

NSE

#MostRead ⚡

This 21-year-old Thane guy has built a Rs 500 crore company that aims to shatter the drug retail industry

Over 2,000 stores across the country, generation of nearly 10,000 jobs, and a company having 500 crores of valuation with the world’s top investors as partners; everything at the age of 21 years.

No, it's not a rags-to-riches story from any bollywood film but a real life tale of 21-year-old desi entrepreneur, Arjun Deshpande, who is a founder and CEO of Generic Adhaar.

While establishing a new ecosystem in the traditional Indian pharmaceutical market, his company aims at solving two persisting problems - accessibility and affordability of medicines. Generic Adhaar, which was started in 2018 when Arjun was 16-year-old, provides high-quality generic medicines directly to end customers by eliminating the chain of intermediaries such as marketers, distributors, and stockists. This helps them in cutting down costs significantly and providing medicines at up to 80-90 percent discounts.

Odisha train accident LIVE | Train movement restarts in Balasore 51 hours after crash

The Odisha triple train accident has left at least 275 people dead and over 1,175 injured. The crash involving Bengaluru-Howrah Superfast Express, the Shalimar-Chennai Central Coromandel Express and a goods train occurred on Friday near the Bahanaga Bazar station in Balasore, about 250 km south of Kolkata and 170 km north of Bhubaneswar.

The incident occurred at around 7 pm on June 2 when 10-12 coaches of the Shalimar-Chennai Coromandel Express derailed, causing them to fall onto the opposite track. The Bengaluru-Howrah Superfast Express collided with the derailed coaches, derailing 3-4 of its own coaches. A goods train was also involved in the crash.

#Featured

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Pinterest Rallies after Q1 Earnings, Revenue Rise Above Expectations; Q2 Revenue Outlook Set
Pinterest Rallies after Q1 Earnings, Revenue Rise Above Expectations; Q2 Revenue Outlook Set
Apr 30, 2024
05:04 PM EDT, 04/30/2024 (MT Newswires) -- Pinterest ( PINS ) was surging 19% in after-hours activity Tuesday after reporting Q1 non-GAAP net income of $0.20 per diluted share, up from $0.08 a year earlier. Analysts polled by Capital IQ expected $0.13. Revenue for the quarter ended March 31 was $740 million, up from $602.6 million a year earlier. Analysts...
Trump raises stake in his media firm to nearly 65%
Trump raises stake in his media firm to nearly 65%
Apr 30, 2024
(Reuters) - Donald Trump has raised his stake in the company that operates his social media app Truth Social to nearly 65% as of last week, according to a filing on Tuesday. The former U.S. president and Republican presidential candidate secured 36 million shares of Trump Media & Technology Group ( DJT ) , increasing his stake from 57.6% as...
OceanaGold Q1 Adjusted Earnings Drop 91% But Says it Remains
OceanaGold Q1 Adjusted Earnings Drop 91% But Says it Remains "On-Track" With FY24 Guidance; Shares Lost 8% Today
Apr 30, 2024
05:30 PM EDT, 04/30/2024 (MT Newswires) -- OceanaGold ( OCANF ) , down 8.3% on Tuesday, after trade reported a 91% drop in adjusted earnings per share in the first quarter but said it is on-track to meet full-year 2024 consolidated production, cost and capital guidance. The company said its adjusted profit, which excludes most one-time items. fell to US$3.7...
FDA approves Neurocrine Biosciences' Huntington's disease drug
FDA approves Neurocrine Biosciences' Huntington's disease drug
Apr 30, 2024
April 30 (Reuters) - The U.S. Food and Drug Administration (FDA) has approved granule formulation of Neurocrine Biosciences' ( NBIX ) drug to treat movement disorders associated with Huntington's disease, the company said on Tuesday. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved